Havrix (Hepatitis A Virus (Inactivated), Algeldrate)

Havrix is indicated for active immunization against hepatitis A virus infection. It is commonly used in the following situations:

• Prevention of hepatitis A in individuals at risk, such as those with chronic liver disease.
• Pre‑travel prophylaxis for people visiting regions where hepatitis A is endemic.
• Immunization of children and adolescents as part of routine vaccination schedules.
• Protection of laboratory personnel handling hepatitis A specimens.
• Outbreak control measures in community or institutional settings.

Side effects of Havrix are generally mild and transient, reflecting the body’s immune response to the vaccine.

Common

• Injection‑site pain, redness, or swelling.
• Low‑grade fever within 24‑48 hours after vaccination.
• Headache or mild fatigue.

Serious

• Severe allergic reaction (anaphylaxis) characterized by difficulty breathing, swelling of the face, or rash.
• Guillain‑Barré syndrome, a rare neurological condition.
• Persistent high fever lasting more than three days.
• Severe joint or muscle pain interfering with daily activities.

Before receiving Havrix, certain precautions should be considered to ensure safe administration:

• Verify that the individual has no known severe allergy to any vaccine component, including algeldrate.
• Defer vaccination in persons with acute moderate or severe illness until recovery.
• Discuss pregnancy and breastfeeding status with a healthcare professional, as safety data are limited.
• Assess immune status; immunocompromised patients may have a reduced antibody response.
• Inform the provider of any history of Guillain‑Barré syndrome.
• Ensure proper storage and handling of the vaccine according to manufacturer guidelines.

Havrix does not have many documented drug interactions, but certain substances may affect its efficacy or safety.

Avoid

• Concurrent administration of live vaccines within four weeks, as it may interfere with immune response.
• Use of immunosuppressive therapies (e.g., high‑dose corticosteroids) immediately before vaccination, which can diminish antibody production.

Use with caution

• Antipyretics such as acetaminophen or ibuprofen taken around the time of injection, which might mask fever.
• Blood products or immunoglobulins given within two weeks before or after vaccination.
• Chronic alcohol consumption, which may impair immune response.
• Any experimental therapies; consult a healthcare professional before co‑administration.